Antares Pharma

One under-$10 stock that's trending very close to trigger a near-term breakout trade is Antares Pharma ( ATRS), which is a specialty pharmaceutical company developing and commercializing self-administered parenteral pharmaceutical products and technologies and topical gel-based products. This stock has been moving higher in 2013, with shares up by 12.4%.

If you take a look at the chart for Antares Pharma, you'll notice that this stock is bouncing sharply to the upside today right off its 50-day moving average of $3.53 a share. This move has started to push shares of ATRS above a key downtrend line that has been acting as resistance for the stock since February. Shares of ATRS are also starting to break out above some near-term overhead resistance at $3.63 to $3.71 a share. That move is quickly pushing the stock within range of triggering another major breakout trade.

>>4 Stocks Spiking on Big Volume

Traders should now look for long-biased trades in ATRS if it manages to break out above some near-term overhead resistance levels at $3.71 to $3.80 a share and then once it clears more resistance at its 200-day at $3.94 and at $4 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 885,916 shares. If that breakout triggers soon, then ATRS will set up to re-test or possibly take out its next major overhead resistance levels at $4.38 to $4.73 a share. Any high-volume move above $4.73 will then put $5.25 to $5.50 into range for shares of ATRS.

Traders can look to buy ATRS off weakness to anticipate that breakout and simply use a stop that sits just below its 50-day at $3.53 a share. One can also buy off strength once ATRS off strength once it takes out those breakout levels with volume and then simply use a stop just below $3.63 a share.

This stock has a decent amount of bears involved in the name, since the current short interest as a percentage of the float for ATRS is pretty high at 9.8%. We could easily see this stock short-squeeze rapidly higher from current levels if the price action remains bullish.

If you liked this article you might like

Biotech Premarket Movers: Sucampo, Intellia, Cytokinetics

Big-Cap Tech Names, Biotechs, Oils Lifting Market

The Pockets of Speculative Action Have Dried Up

Shark Bites: Entry Points Are Scarce

Weak On High Volume: Sucampo Pharmaceuticals (SCMP)